Apolipoprotein E4 and coronary heart disease in middle-aged men who smoke: a prospective study
- 1 July 2001
- journal article
- Published by Elsevier in The Lancet
- Vol. 358 (9276) , 115-119
- https://doi.org/10.1016/s0140-6736(01)05330-2
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- The Apolipoprotein ε4 Allele Determines Prognosis and the Effect on Prognosis of Simvastatin in Survivors of Myocardial InfarctionCirculation, 2000
- The Apolipoprotein E and β-Fibrinogen G/A-455 Gene Polymorphisms Are Associated With Ischemic Stroke Involving Large-Vessel DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- The insulin resistance syndrome and postprandial lipid intolerance in smokersAtherosclerosis, 1997
- Apolipoprotein E Alleles and Risk of Coronary DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 1996
- Increased levels of autoantibodies to cardiolipin and oxidised low density lipoprotein are inversely associated with plasma vitamin C status in cigarette smokersAtherosclerosis, 1996
- Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset FamiliesScience, 1993
- Blood viscosity and cardiovascular riskCurrent Opinion in Lipidology, 1993
- The human beta fibrinogen promoter contains a hepatocyte nuclear factor 1-dependent interleukin-6-responsive element.Molecular and Cellular Biology, 1993
- The effect of cigarette smoke, nicotine, and carbon monoxide on the permeability of the arterial wallJournal of Vascular Surgery, 1988
- Apolipoprotein E polymorphism and atherosclerosis.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1988